Abstract
Pyoderma gangrenosm is a neutrophilic dermatosis characterised by rapidly spreading and painful ulceratve lesions. Wegener’s granulomatosus, a small vessel vasculitis can present with cutaneous features in approximaely 10% of patients. There can be subcutaneous nodules, papulonecrotic lesions, ulcers which may resemble pyoderma gangrenosum so called ‘malignant pyoderma’. We hereby report a rare case of 30 year old female with multiple pyoderma gangrenosum lesions associated with upper respiratory tract, ear, sinus involvement with positive p-ANCA subsequently diagnosed as limited wegener’sgranulomatosus with pyoderma gangrenosum. Patient was treated with steroids and immunosuppressives showed significant improvement over time.
Keywords: Pyoderma Gangrenosum, Wegeners granulomatosis , pANCA.
References
1. Von den Driesch P. Pyoderma gangrene-osum: a report of 44 cases with follow-up.Br J Dermatol1997; 137: 1000–5.
2. Jackson JM, Callen JP. Pyoderma gangrenosum: an expert commentary. Expert Rev Dermatol2006; 1: 391–400.
3. Wollina U. Pyoderma gangrenosum—a review. Orphanet J Rare Dis 2007; 2: 19.
4. Handfield-Jones SE, Parker SC, Fenton DA, et al. Wegener's granulomatosis pres-enting as pyoderma gangrenosum. Clin Exp Dermatol 1992; 17:197–200.
5. Hoffman GS, Kerr GS, Leavitt RY et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488–98.
6. Yi ES, Colby TV. Wegener’s granulom-atosis. SeminDiagPathol2001; 18: 34–46.
7. Cotch MF, Hoffman GS, Yerg DE et al. The epidemiology of Wegener’s granulo-matosis. Estimates of the five-year period prevalence, annual mortality, and geogr-aphic diseases distribution from population-based data sources. Arthritis Rheum 1996; 39: 87–92.
8. Bambery P, Sakhuja V, Gupta A et al. Wegener's granulomatosis in north India. Radiological manifestations in eleven patients. ActaRadwtogica1988; 29: l1-13.
9. Rao JK, Weinberger M, Oddone EZ et al. The role of antineutrophil cytoplasmic antibody testing in the diagnosis of Wegener granulomatosis. Ann Intern Med 1995; 123: 925–32.
10. Agarwal PK, Gogia A. Limited Wegener's granulomatosis with p-ANCA positivity. Jour IndAcadclin med 2004;5:348–50
11. Cone LA, Annunziata GM, Gebhart RN. Malignant Pyoderma and Wegener’s Granulomatosis. Letter to the editor. Mayo Clin Proc 1998;73: 390–1.
12. Kouba DJ, Mimouni D, Ha CT, et al. Limited Wegener's granulomatosis manife-sting as malignant pyoderma with corneal melt. Int J Dermatol 2003; 42:902–4.
13. Kędzierska K, Sindrewicz K, Smektała T, Wiśniewska M, Masiuk M, Staniszewska E, Sporniak-Tutak K, Gołembiewska E, Ciechanowski K. Wegener’s granulo-matosis and pyoderma gangrenosum–rare causes of facial ulcerations. Post ȩpyhigienyimedycynydoświadczalnej (Online). 2016 Mar 16;70:210-12.
14. Boudny C., Nievergelt H., Braathen L.R., Simon D.: Wegener’s granulomatosis presenting as pyoderma gangrenosum. J. Dtsch.Dermatol. Ges., 2008; 6: 477-9.
15. Cone LA, Annunziata GM, Gebhart RN. Malignant pyoderma and Wegener's granulomatosis. Mayo Clin Proc 1998; 73:390-1.
DOI: https://dx.doi.org/10.18535/jmscr/v5i2.81
